Another study, conducted on Chinese NAFLD patients, found that the PNPLA3 GG genotype escalates liver steatosis but reduces the risk of DM2T in patients with obesity or IR [207]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.